Rhythm Pharmaceuticals (RYTM) EBITDA Margin (QoQ) (2021 - 2026)
Rhythm Pharmaceuticals (RYTM) EBITDA Margin (QoQ) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Rhythm Pharmaceuticals |
6.59 Bn |
6.25 Bn |
52.96 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-829.00 |
| Dec 31, 2025 |
2,044.00 |
| Sep 30, 2025 |
-925.00 |
| Jun 30, 2025 |
6,204.00 |
| Mar 31, 2025 |
-5,681.00 |
| Dec 31, 2024 |
3,336.00 |
| Sep 30, 2024 |
722.00 |
| Jun 30, 2024 |
39,951.00 |
| Mar 31, 2024 |
-36,843.00 |
| Dec 31, 2023 |
2,503.00 |
| Sep 30, 2023 |
4,715.00 |
| Jun 30, 2023 |
21,556.00 |
| Mar 31, 2023 |
-98,117.00 |
| Dec 31, 2022 |
143,975.00 |
| Sep 30, 2022 |
-41,918.00 |
| Jun 30, 2022 |
302,000.00 |
| Mar 31, 2022 |
-71,120.00 |
| Dec 31, 2021 |
149,728.00 |
| Sep 30, 2021 |
1.05 Mn |
| Jun 30, 2021 |
8.35 Mn |
